APA (7th ed.) Citation

MK, A., MA, A., KS, A., GS, E., MA, E. K., NM, E. F., . . . NM, T. (2023). FA-HA-Amygdalin@Fe2O3 and/or γ-Rays Affecting SIRT1 Regulation of YAP/TAZ-p53 Signaling and Modulates Tumorigenicity of MDA-MB231 or MCF-7 Cancer Cells. Current cancer drug targets, 23(2), 118. https://doi.org/10.2174/1568009622666220816123508

Chicago Style (17th ed.) Citation

MK, Abdel-Rafei, Askar MA, Azab KS, El-Sayyad GS, El Kodous MA, El Fatih NM, Tawill GE, and Thabet NM. "FA-HA-Amygdalin@Fe2O3 And/or γ-Rays Affecting SIRT1 Regulation of YAP/TAZ-p53 Signaling and Modulates Tumorigenicity of MDA-MB231 or MCF-7 Cancer Cells." Current Cancer Drug Targets 23, no. 2 (2023): 118. https://doi.org/10.2174/1568009622666220816123508.

MLA (9th ed.) Citation

MK, Abdel-Rafei, et al. "FA-HA-Amygdalin@Fe2O3 And/or γ-Rays Affecting SIRT1 Regulation of YAP/TAZ-p53 Signaling and Modulates Tumorigenicity of MDA-MB231 or MCF-7 Cancer Cells." Current Cancer Drug Targets, vol. 23, no. 2, 2023, p. 118, https://doi.org/10.2174/1568009622666220816123508.